Paul Pearlman, Acting Chief of the Imaging Technology Development Branch at National Cancer Institute (NCI), shared on LinkedIn:
“After 13 incredible years at the NCI Center for Global Health, I am writing to share that I am taking on a new role at the National Cancer Institute (NCI).
I am thrilled to announce that I have stepped into the position of Acting Chief of the Imaging Technology Development Branch in the Cancer Imaging Program, within the Division of Cancer Treatment and Diagnosis (DCTD).
Reflecting on my time at CGH fills me with immense gratitude. To my colleagues, collaborators, and friends at CGH, thank you for your tireless dedication and shared passion. It has been the privilege of a lifetime to work alongside you to reduce the global burden of cancer.
While it is bittersweet to turn this page, I look forward to working with my new colleagues in the Cancer Imaging Program to support and accelerate innovations that elevate both the quality and accessibility of cancer diagnosis and treatment planning.”
Other articles featuring Paul Pearlmanon OncoDaily.